Citius Oncology, Inc.
CTOR · NASDAQ
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $149 | $99 | $1,023 | $1,031 |
| - Cash | $4 | $0 | $0 | $0 |
| + Debt | $4 | $4 | $0 | $0 |
| Enterprise Value | $149 | $103 | $1,023 | $1,030 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$23 | -$21 | -$12 | -$5 |
| % Margin | – | – | – | – |
| Net Income | -$25 | -$21 | -$13 | -$5 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.34 | -0.3 | -0.19 | -0.076 |
| % Growth | -13.3% | -57.9% | -149% | – |
| Operating Cash Flow | -$5 | $0 | -$1 | -$0 |
| Capital Expenditures | -$6 | -$5 | $0 | $0 |
| Free Cash Flow | -$11 | -$5 | -$1 | -$0 |